Edition:
India

Edge Therapeutics Inc (EDGE.OQ)

EDGE.OQ on NASDAQ Stock Exchange Global Select Market

9.33USD
12:53am IST
Change (% chg)

$-0.08 (-0.85%)
Prev Close
$9.41
Open
$9.39
Day's High
$9.90
Day's Low
$9.33
Volume
6,701
Avg. Vol
19,318
52-wk High
$13.37
52-wk Low
$7.44

Chart for

About

Edge Therapeutics, Inc. is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening critical care conditions. The Company's initial product candidates target rare, acute, life-threat... (more)

Overall

Beta: --
Market Cap(Mil.): $340.91
Shares Outstanding(Mil.): 30.85
Dividend: --
Yield (%): --

Financials

BRIEF-Edge Therapeutics reports qtrly loss per share $‍0.37​

* Edge Therapeutics reports third quarter 2017 financial results

01 Nov 2017

BRIEF-Edge Therapeutics appoints Rosemary Crane to Board of Directors

* Edge Therapeutics appoints Rosemary A Crane, pharmaceutical industry leader, to its Board Of Directors

19 Sep 2017

BRIEF-Edge Therapeutics to pay Oakwood $4.5 mln on achievement of regulatory milestones

* Edge Therapeutics - under restated development agreement, agreed to pay oakwood $4.5 million on achievement of regulatory milestones,no later than Apr 1 2019 Source: (http://bit.ly/2ttB0pm) Further company coverage:

06 Jul 2017

BRIEF-Edge Therapeutics enters commercial supply agreement for EG-1962 with Oakwood Laboratories

* Edge Therapeutics announces commercial supply agreement for EG-1962 with Oakwood Laboratories

06 Jul 2017

BRIEF-Edge Therapeutics receives pediatric investigation plan waiver from European medicines agency

* Edge Therapeutics receives pediatric investigation plan waiver from the European medicines agency Source text for Eikon: Further company coverage:

08 Jun 2017

Earnings vs. Estimates